Literature DB >> 27299520

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.

Harold R Collard1, Christopher J Ryerson2, Tamera J Corte3, Gisli Jenkins4, Yasuhiro Kondoh5, David J Lederer6, Joyce S Lee7, Toby M Maher8,9, Athol U Wells9, Katerina M Antoniou10, Juergen Behr11, Kevin K Brown12, Vincent Cottin13, Kevin R Flaherty14, Junya Fukuoka15, David M Hansell16, Takeshi Johkoh17, Naftali Kaminski18, Dong Soon Kim19, Martin Kolb20, David A Lynch21, Jeffrey L Myers22, Ganesh Raghu23, Luca Richeldi24, Hiroyuki Taniguchi5, Fernando J Martinez25.   

Abstract

Acute exacerbation of idiopathic pulmonary fibrosis has been defined as an acute, clinically significant, respiratory deterioration of unidentifiable cause. The objective of this international working group report on acute exacerbation of idiopathic pulmonary fibrosis was to provide a comprehensive update on the topic. A literature review was conducted to identify all relevant English text publications and abstracts. Evidence-based updates on the epidemiology, etiology, risk factors, prognosis, and management of acute exacerbations of idiopathic pulmonary fibrosis are provided. Finally, to better reflect the current state of knowledge and improve the feasibility of future research into its etiology and treatment, the working group proposes a new conceptual framework for acute respiratory deterioration in idiopathic pulmonary fibrosis and a revised definition and diagnostic criteria for acute exacerbation of idiopathic pulmonary fibrosis.

Entities:  

Keywords:  acute exacerbation; diagnosis; management; pulmonary fibrosis; review

Mesh:

Year:  2016        PMID: 27299520     DOI: 10.1164/rccm.201604-0801CI

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  293 in total

1.  Pharmacological treatment of acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study of 88 patients.

Authors:  Susumu Sakamoto; Hiroshige Shimizu; Takuma Isshiki; Atsuko Kurosaki; Sakae Homma
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

2.  Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature.

Authors:  Andreina Manfredi; Marco Sebastiani; Stefania Cerri; Caterina Vacchi; Roberto Tonelli; Giovanni Della Casa; Giulia Cassone; Amelia Spinella; Pancaldi Fabrizio; Fabrizio Luppi; Carlo Salvarani
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

3.  Update in Interstitial Lung Disease 2016.

Authors:  Athol U Wells; Toby M Maher
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

4.  Highlights from the 2018 European Respiratory Society Congress presentations on interstitial lung diseases.

Authors:  Tiago M Alfaro; Margarida Afonso; Sebastiano Emanuele Torrisi
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

5.  [Chronic fibrosing lung diseases : Idiopathic pulmonary fibrosis from the perspective of its differential diagnosis].

Authors:  R C Dartsch; L Fink; A Breithecker; P Markart; S Tello; W Seeger; A Günther
Journal:  Internist (Berl)       Date:  2019-04       Impact factor: 0.743

6.  A case of maoto-induced interstitial pneumonia.

Authors:  Masaru Ando; Taiki Masuda; Mari Yamasue; Shin-Ichi Nureki; Eishi Miyazaki; Jun-Ichi Kadota
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

7.  Role of B7H3/IL-33 Signaling in Pulmonary Fibrosis-induced Profibrogenic Alterations in Bone Marrow.

Authors:  Taku Nakashima; Tianju Liu; Biao Hu; Zhe Wu; Matthew Ullenbruch; Keitaro Omori; Lin Ding; Noboru Hattori; Sem H Phan
Journal:  Am J Respir Crit Care Med       Date:  2019-10-15       Impact factor: 21.405

Review 8.  Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.

Authors:  Jeremy Katzen; Michael F Beers
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 9.  Acute Exacerbation of Idiopathic Pulmonary Fibrosis.

Authors:  Tomoo Kishaba
Journal:  Eurasian J Med       Date:  2017-10

10.  What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?

Authors:  Masahiro Miyajima; Atsushi Watanabe; Toshihiko Sato; Satoshi Teramukai; Masahito Ebina; Kazuma Kishi; Yukihiko Sugiyama; Haruhiko Kondo; Satoru Kobayashi; Yutaka Takahashi; Hiroyuki Ito; Ryoji Yamamoto; Shigeki Sawada; Hideki Fujimori; Kazunori Okabe; Jun Arikura; Yasushi Shintani; Hiroshige Nakamura; Shinichi Toyooka; Tohru Hasumi; Takehiro Watanabe; Yoshinobu Hata; Hisashi Iwata; Minoru Aoki; Kazuhito Funai; Shuhei Inoue; Osamu Kawashima; Tomohiko Iida; Hiroshi Date
Journal:  Surg Today       Date:  2017-11-09       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.